Kolon Tissuegene, Inc.

Kolon Tissuegene, Inc. company information, Employees & Contact Information

Explore related pages

Kolon Tissuegene, Inc. email format Kolon Tissuegene, Inc. management contacts

Related company profiles:

Kolon TissueGene, Inc. is a biotechnology company developing advanced cell therapies to target various orthopedic diseases and degenerative disorders. Kolon TissueGene, Inc. is based out of 9713 Key West Ave, Suite 300, Rockville, MD-20850.

Company Details

Employees
63
Founded
-
Address
9713 Key West Ave, Rockville,maryland 20850,united States
Phone
(301)921-6000
Email
in****@****ene.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
tissuegene.com
Keywords
Cell and Gene Thereapy and Biopharmaceutical Research.
HQ
Rockville, Maryland
Competitors
AstraZeneca, Kolon Industries, Inc, Kolon Global Corp (003070), Novavax, REGENXBIO, Catalent, Lonza, Supernus Pharmaceuticals, Inc., KOLON Life Science, Inc. (코오롱생명과학), Granules Pharmaceuticals, Inc..
Looking for a particular Kolon Tissuegene, Inc. employee's phone or email?

Kolon Tissuegene, Inc. Questions

News

KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS - PR Newswire

KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS PR Newswire

Kolon TissueGene’s Osteoarthritis Therapy TG-C Gains Momentum for U.S. FDA Approval - Businesskorea

Kolon TissueGene’s Osteoarthritis Therapy TG-C Gains Momentum for U.S. FDA Approval Businesskorea

Kolon TissueGene moves arthritis gene therapy into spine trial after FDA green light - koreabiomed.com

Kolon TissueGene moves arthritis gene therapy into spine trial after FDA green light koreabiomed.com

There was trial and error, but I think I was able to come this far because I developed it with conf.. - 매일경제

There was trial and error, but I think I was able to come this far because I developed it with conf.. 매일경제

Kolon TissueGene taps ex-Daewoong CEO to tackle financial woes, boost drug development - koreabiomed.com

Kolon TissueGene taps ex-Daewoong CEO to tackle financial woes, boost drug development koreabiomed.com

Kolon TissueGene's osteoarthritis treatment expected to gain FDA approval by 2028 - CHOSUNBIZ - Chosun Biz

Kolon TissueGene's osteoarthritis treatment expected to gain FDA approval by 2028 - CHOSUNBIZ Chosun Biz

Press Release Service: Advanced Therapy Medicinal Products Global Strategic Business Report 2025, with Profiles of Bluebird Bio, Gilead Sciences, JCR Pharmaceuticals, Kolon TissueGene, MediPost, Organogenesis and more - ResearchAndMarkets.com - CRISPR Medicine News

Press Release Service: Advanced Therapy Medicinal Products Global Strategic Business Report 2025, with Profiles of Bluebird Bio, Gilead Sciences, JCR Pharmaceuticals, Kolon TissueGene, MediPost, Organogenesis and more - ResearchAndMarkets.com CRISPR Medicine News

Kolon TissueGene Raises $29.6 Million from Korean Parent and Chairman to Sustain Phase 3 Clinical Trials - citybiz

Kolon TissueGene Raises $29.6 Million from Korean Parent and Chairman to Sustain Phase 3 Clinical Trials citybiz

Hypergraph factorization for multi-tissue gene expression imputation - Nature

Hypergraph factorization for multi-tissue gene expression imputation Nature

US FDA Maintains Clinical Hold on Kolon Tissuegene's Invossa - FirstWord Pharma

US FDA Maintains Clinical Hold on Kolon Tissuegene's Invossa FirstWord Pharma

Kolon resumes Invossa phase 3 clinical trials in US - The Korea Economic Daily Global Edition

Kolon resumes Invossa phase 3 clinical trials in US The Korea Economic Daily Global Edition

Mitsubishi strengthens arthritis portfolio with TissueGene deal - BioPharma Dive

Mitsubishi strengthens arthritis portfolio with TissueGene deal BioPharma Dive

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment - Nature

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment Nature

Kolon TissueGene’s osteoarthritis therapy TG-C completes phase 3 FDA trial - 조선일보

Kolon TissueGene’s osteoarthritis therapy TG-C completes phase 3 FDA trial 조선일보

Kolon TissueGene completes patient dosing in phase 3 osteoarthritis gene therapy study - koreabiomed.com

Kolon TissueGene completes patient dosing in phase 3 osteoarthritis gene therapy study koreabiomed.com

Will Kolon’s new osteoarthritis treatment secure FDA approval this time? - 조선일보

Will Kolon’s new osteoarthritis treatment secure FDA approval this time? 조선일보

Will Kolon TissueGene get out of ‘delisting crisis’ caused by Invossa? - koreabiomed.com

Will Kolon TissueGene get out of ‘delisting crisis’ caused by Invossa? koreabiomed.com

Kolon TissueGene shares to resume trading on Kosdaq from Oct.25 - koreabiomed.com

Kolon TissueGene shares to resume trading on Kosdaq from Oct.25 koreabiomed.com

Is Kolon TissueGene's Invossa set to make a comeback? - koreabiomed.com

Is Kolon TissueGene's Invossa set to make a comeback? koreabiomed.com

Court upholds nixing permit for Kolon Life Science's gene therapy Invossa - koreabiomed.com

Court upholds nixing permit for Kolon Life Science's gene therapy Invossa koreabiomed.com

Cell mediated gene therapy: A guide for doctors in the clinic - Baishideng Publishing Group

Cell mediated gene therapy: A guide for doctors in the clinic Baishideng Publishing Group

Kolon Life inks technology transfer deal with Juniper Biologics - The Korea Economic Daily Global Edition

Kolon Life inks technology transfer deal with Juniper Biologics The Korea Economic Daily Global Edition

Delays in court rulings raise business risks for South Korean companies - The Korea Economic Daily Global Edition

Delays in court rulings raise business risks for South Korean companies The Korea Economic Daily Global Edition

Why did Kolon change Invossa contract manufacturer to Lonza? - koreabiomed.com

Why did Kolon change Invossa contract manufacturer to Lonza? koreabiomed.com

Tensor decomposition for multiple-tissue gene expression experiments - Nature

Tensor decomposition for multiple-tissue gene expression experiments Nature

Merck & TissueGene’s Drugs to Change Osteoarthritis Market - drugdiscoverytrends.com

Merck & TissueGene’s Drugs to Change Osteoarthritis Market drugdiscoverytrends.com

Antrogen Nears Approval in Japan [K-Bio Pulse] - 팜이데일리

Antrogen Nears Approval in Japan [K-Bio Pulse] 팜이데일리

TissueGene promotes cell gene therapy Invossa ahead of IPO - koreabiomed.com

TissueGene promotes cell gene therapy Invossa ahead of IPO koreabiomed.com

Korea Investment & Securities maintained its target stock price of 100,000 won on the 15th, sayi.. - 매일경제

Korea Investment & Securities maintained its target stock price of 100,000 won on the 15th, sayi.. 매일경제

FDA Notifies Kolon TissueGene to Maintain Clinical Hold on Invossa - 동아사이언스

FDA Notifies Kolon TissueGene to Maintain Clinical Hold on Invossa 동아사이언스

Kolon TissueGene contests delisting decision, works to renew phase 3 clinical trial in US - 매일경제

Kolon TissueGene contests delisting decision, works to renew phase 3 clinical trial in US 매일경제

Kolon TissueGene was aware of risky cell alterations in treatment for 2 years - 한겨레

Kolon TissueGene was aware of risky cell alterations in treatment for 2 years 한겨레

Patients injected with gene therapy treatment initiate class action lawsuit against Kolon Life Science - 한겨레

Patients injected with gene therapy treatment initiate class action lawsuit against Kolon Life Science 한겨레

Companies like Kolon Tissuegene, Inc.

Novavax logo - Similar company to Kolon Tissuegene, Inc.

Novavax

1.07K
AstraZeneca logo - Similar company to Kolon Tissuegene, Inc.

Astrazeneca

78.61K
Kolon Industries, Inc logo - Similar company to Kolon Tissuegene, Inc.

Kolon Industries, Inc

706
Catalent logo - Similar company to Kolon Tissuegene, Inc.

Catalent

12.87K
Supernus Pharmaceuticals, Inc. logo - Similar company to Kolon Tissuegene, Inc.

Supernus Pharmaceuti...

741
REGENXBIO logo - Similar company to Kolon Tissuegene, Inc.

Regenxbio

389
Lonza logo - Similar company to Kolon Tissuegene, Inc.

Lonza

18.17K
Granules Pharmaceuticals, Inc. logo - Similar company to Kolon Tissuegene, Inc.

Granules Pharmaceuti...

437
KOLON Life Science, Inc. (코오롱생명과학) logo - Similar company to Kolon Tissuegene, Inc.

Kolon Life Science, ...

130
Kolon Global Corp (003070) logo - Similar company to Kolon Tissuegene, Inc.

Kolon Global Corp (0...

233

Top Kolon Tissuegene, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant